IL-1β promoted ESCC development, which can be achieved by activating the PI3K/AKT/FOXO3A signaling pathway, promoting EMT processogenesis and inhibiting autophagy. The gene discussed is AKT1; the disease is esophageal squamous cell carcinoma.